Title : A cost-effectiveness analysis of anemia screening before erythropoietin in patients with end-stage renal disease.

Pub. Date : 1997 May

PMID : 9159297






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The treatment efficacy of erythropoietin (EPO) in end-stage renal disease (ESRD) can be limited by deficiencies of iron, folate, or vitamin B12, by hyperparathyroidism, or by aluminum intoxication. Aluminum erythropoietin Homo sapiens
2 The treatment efficacy of erythropoietin (EPO) in end-stage renal disease (ESRD) can be limited by deficiencies of iron, folate, or vitamin B12, by hyperparathyroidism, or by aluminum intoxication. Aluminum erythropoietin Homo sapiens